JamesRSeiboldMD

PubMed

• 11 citations
  Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.
  David Roofeh, Kevin K Brown, Ella A Kazerooni, Donald Tashkin, Shervin Assassi
  Rheumatology. 2023-05-02
• 45 citations
  Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial.
  Eric L Matteson, Clive Kelly, Jörg H W Distler, Anna-Maria Hoffmann-Vold, James R Seibold
  Arthritis & Rheumatology. 2022-06-01
• 14 citations
  Pharmacological treatments for SSc-ILD: Systematic review and critical appraisal of the evidence.
  Madelon C. Vonk, Vanessa Smith, Petros P. Sfikakis, Maurizio Cutolo, Francesco Del Galdo
  Autoimmunity Reviews. 2021-10-28

Journal Articles

• Progress and priorities in systemic sclerosis: the next ten years-report from the World Scleroderma Foundation  
  Furst DE, Pope JE, Seibold JR, Bombardieri S, Denton CP, Distler O, Kahaleh B, Kennedy AT, Khanna D, Lafyatis R, Tyndall AD, Matucci-Cerinic M, J Scleroderma Rel Disorders, 1/1/2016
• The American College of Rheumatology provisional composite response index for clinical trials in early diffuse cutaneous systemic sclerosis  
  Khanna D, Berrocal VJ, Giannini E, Seibold JR, Merkel PA, Mayes MD, Baron M, Clements PJ, Steen VD, Assassi S, Schiopu E, Phillips K, Simms R, Allanore Y, Denton CP, D..., Arthritis Rheum, Arthritis Care Res, 1/1/2016
• Connective Tissue Disease Related Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: Provisional Core-Sets of Domains and Instruments for Use in Clinical Tr...  
  Saketkoo LA, Mittoo S, Huscher D, Dellaripa PF, Distler O, Flaherty K, Frankel S, Khanna D, Oddis CV, Denton CP , Fischer A, Kowal-Bielecka OM, LeSage D, Merkel P, Phi..., Thorax, 1/20/2014
• Borderline pulmonary arterial pressure in scleroderma: Are systemic sclerosis patients with borderline pulmonary arterial pressure a unique subset? A post-hoc analysis...  
  Visovatti S, Distler O, Coghlan JG, Denton CP, Gruenig E, Bonderman D, Mueller-Ladner U, Pope JE, Vonk MC, Seibold JR, Torres-Martin J-V, Doelberg M, Chadha-Boreham H,..., Arthritis Res Ther, 1/10/2014
• Twenty-two Points to Consider for clinical trials in systemic sclerosis, based on EULAR Standards  
  Khanna D, Furst DE, Allanore Y, Bae S, Bodukam V,Clements PJ, Cutolo M, Seibold JR, Cutolo M, Czirjak L, Denton CP, Distler O, Walker UA, Matucci-Cerinic M, Mueller-La..., Rheumatology, 1/1/2014
• Recognition of pulmonary hypertension in the community-lessons from a Quality Enhancement Research Initiative  
  Khanna D, Tan M, Furst DE, Hill N, McLaughlin V, Silver RM, Steen VD, Langer A, Seibold JR, Clin Exp Rheumatol, 1/1/2014
• Correlates and responsiveness of skin and musculoskeletal disease in early diffuse systemic sclerosis  
  Wiese AB, Berrocal VJ, Furst DE, Seibold JR, Merkel PA, Mayes MD, Khanna D, Arthritis Care Res, 1/1/2014
• Systemic sclerosis classification criteria: developing methods for multi-criteria decision analysis with 1000 minds  
  Johnson S, Naden RP, Fransen J, van den Hoogen F, Pope JE, Baron M, Tyndall A, Matucci-Cerinic M, Denton CP, Distler O, Gabrielli A, van Laar JM, Mayes M, Steen V, Sei..., J Clin Epidemiol, 1/1/2014
• Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related intersti...  
  Saketkoo LA, Mittoo S, Frankel S, LeSage D, Sarver C, Phillips K, Strand V, Matteson EL, OMERACT Connective Tissue Disease-Interstitial Lung Diseases Working Group (Se..., J Rheumatol, 1/1/2014
• Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation wit...  
  Shah AA, Schiopu E, Hummers LK, Wade M, Phillips K, Anderson C, Wise R, Boin F, Seibold JR, Wigley F, Rollins KD, Arthritis Res Ther, 1/18/2013
• A Delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis (SSc) using SSc experts and databases  
  Coulter C, Baron M, Pope J on behalf of others including Seibold JR, Clin Exp Rheumatol, 1/1/2013
• Survival in systemic sclerosis with pulmonary arterial hypertension has not improved in the modern era  
  Rubenfire M, Huffman M, Krishnan SM, Seibold JR, Schiopu E, McLaughlin VV, Chest, 1/1/2013
• Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis A randomized, placebo-phase trial  
  Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman D, Levesque MC, Barohn RJ, Feldman BM, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rockette HE and the Rit..., Arthritis Rheum, 1/1/2013
• Gastric antral vascular ectasia (GAVE) and its clinical correlates in early diffuse systemic sclerosis  
  Hung EW, Mayes MD, Sharif R, Assassi S, Machicao VI, Hosing C, St. Clair W, Furst DE, Khanna D, Forman S, Mineishi S, Phillips K, Seibold JR, Bredeson C, Csuka ME, Nas..., J Rheumatol, 1/1/2013
• Systemic sclerosis-continuing progress in developing clinical measures of outcome  
  Furst DE, Khanna D, Matucci-Cerinic M, Clements P, Steen VD, Pope J, Merkel P, Foeldvari I, Seibold J, Pittrow D, Polisson R, Strand V, J Rheumatol, 1/1/2013
• Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis, the DETECT study  
  Coghlan JG, Denton CP, Gruenig E, Bonderman D, Distler O, Khanna D, Mueller-Ladner U, Pope JE, Vonk MC, Doelberg M, Chadha-Boreham H, Heizl H, Rosenberg D, McLaughlin ..., Ann Rheum Dis, 1/1/2013
• Classification criteria for systemic sclerosis: An ACR-EULAR Collaborative Initiative  
  van de Hoogen F, Khanna D, Fransen J, Johnson S, Baron M, Tyndall A, Matucci-Cerinic M, Naden R, Medsger TA, Carreira P, Riemekasten G, Clements PJ, Denton CP, Distler..., Arthritis Rheum, 1/1/2013
• Patterns and predictors of change in outcome measures in clinical trials in scleroderma: An individual patient meta-analysis of 629 subjects with diffuse scleroderma  
  Merkel PA, Silliman NP, Clements PJ, Denton CP, Furst DE, Mayes MD, Pope JE, Polisson RP, Streisand JB, Seibold JR, Arthritis Rheum, 1/1/2012
• Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma fibroblasts  
  Tsou P-S, Talia NN, Pinney AJ, Piera S, Jimenez SA, Seibold JR, Phillips K, Koch AE, Arthritis Rheum, 1/1/2012
• Items for revised classification criteria in systemic sclerosis: results of a consensus exercise with the EULAR/ACR working group for classification criteria in system...  
  Fransen J, Johnson SR, van den Hoogen F, Baron, M, Allanore Y, Carreira P, Czirjak L, Denton C, Distler O, Furst D, Gabrielli A. Herrick A, Inanc M, Kahaleh B, Kowal-B..., Arthritis Care Research, 1/1/2012
• Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial hypertension in systemic sclerosis: results from...  
  Baes S, Saggar R, Bolster MB et al for the PHAROS Group (Seibold JR), Ann Rheum Dis, 1/1/2012
• Expert consensus for performing right heart catheterization for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster ...  
  Avouac J, Huscher D, Furst DE, Opitz CF, Distler O, Allanore Y for the EPOSS Group (Seibold JR), Ann Rheum Dis, 1/1/2012
• Treatment of systemic sclerosis complications: what to use when first-line treatment fails-a consensus of systemic sclerosis experts  
  Walker KM, Pope J, Scleroderma Clinical Trials Consortium (Seibold JR), Canadian Scleroderma Research Group, Sem Arthr Rheum, 1/1/2012
• Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial  
  Matucci-Cerinic M, Denton CP, Furst DE, Matucci-Cerinic M, Mayes MD, Morganti A, Kramer F, Korn JH, Seibold JR, Ann Rheum Dis, 1/1/2011
• Gender and ethnicity differences in patients with diffuse systemic sclerosisAnalysis from 3 large randomized clinical trials  
  Nashid M, Khanna PP, Furst DE, Clements PJ, Maranian P, Seibold JR, Postlethwaite AE, Luoie J, Mayes MD, Agrawal H, Khanna D, Rheumatol, 1/1/2011
• Join now to see all

Books/Book Chapters

• Case Studies in Systemic Sclerosis 
  Chapter: Rapidly progressive skin disease in a patient with diffuse systemic sclerosis. 
  Schiopu E, Seibold JREditors: Denton CP, Silver RM.Springer2011
• Challenging Cases in Allergic and Immunologic Diseases of the Skin 
  Chapter: Scleroderma. 
  Schiopu E, Seibold JREditors: Mahmoudi M.Springer Science+Business Media, LLC2010
• Advances in Vascular Medicine 
  Chapter: PAH in CTD-Clinical Trials Criteria and Performance. 
  Page 274 - 287Seibold JREditors: Abraham D, Handler C, Dashwood M, Coghlan G.Springer-Verlag London LtdEdition 1st,2010
• Pulmonary Arterial Hypertension in Connective Tissue Disease 
  Chapter: Front-line screening and diagnosis of PAH: What new cardiopulmonary guidelines tell us. 
  Page 6 - 9Seibold JRNew York2007
• Pulmonary Arterial Hypertension in Connective Tissue Disease 
  Chapter: The lung and beyond: future directions in treatment of systemic sclerosis complications. 
  Page 20 - 22Seibold JRNew York2007
• Primer of the Rheumatic Diseases 
  Chapter: Systemic Sclerosis C. Treatment and Assessment. 
  Page 359 - 362Buch MH, Seibold JREditors: Stone JH, Crofford LJ, White PH.Springer, New YorkEdition 13th,2007
• Voices of Scleroderma 
  Chapter: Introduction. 
  Page 29 - 30Seibold JREditors: Devlin JT, Ensz SL.International Scleroderma Network Press, Edina, MN2006
• Kelley's Textbook of Rheumatology 
  Chapter: Systemic Sclerosis. 
  Page 1279 - 1308Seibold JREditors: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB.Elsevier Saunders, PhiladelphiaEdition 7th,2005
• Yearbook of Rheumatology, Arthritis and Musculoskeletal Disease 
  Chapter: Systemic sclerosis and related disorders. 
  Page 141 - 184Seibold JREditors: Panush RS, Hadler NM, Hellmann DB, Lahita RG, Lane NE and Seibold JR.Elsevier2004
• Systemic Sclerosis 
  Chapter: Disease modifying treatments of systemic sclerosis. 
  Page 351 - 361Seibold JR, Clements P, Furst DEEditors: Clements PJ, Furst DE.Lippincott Williams & Wilkins, PhiladelphiaEdition 2nd,2004
• Vascular Manifestations of Systemic Autoimmune Diseases 
  Chapter: Treatment of Raynaud's Phenomenon. 
  Page 571 - 578Matucci Cerinic M, Generini S, Seibold JREditors: Asherson, Cervera, Tripplet, Abramson.CRC Press, London2001
• Kelley's Textbook of Rheumatology 
  Chapter: Seibold JR 
  Page 1211 - 1239Seibold JREditors: Ruddy S, Harris ED, Sledge CB, Budd RC, Sergent JS.WB Saunders, PhiladelphiaEdition 6th,2000
• Kelley's Textbook of Internal Medicine 
  Chapter: Scleroderma and Raynaud's Phenomenon. Rapid Access Guide. 
  Seibold JREditors: Fine PL, Humes HD.Lippincott Williams & Wilkins, PhiladelphiaEdition 4th,2000
• Textbook of Rheumatology 
  Chapter: Textbook of Rheumatology 
  Page 1133 - 1162Seibold JREditors: Kelley WN, Harris ED, Ruddy S, Sledge CB.W.B. Saunders, PhiladelphiaEdition 5th,1997
• Rapid Access Guide to Internal Medicine 
  Chapter: Scleroderma. 
  Page 178 - 179Seibold JREditors: O'Kane P.PhiladelphiaEdition 3rd,1997
• Textbook of Internal Medicine 
  Chapter: Scleroderma and Raynaud's Syndrome. 
  Page 1149 - 1154Seibold JREditors: Kelley WN.PhiladelphiaEdition 3rd,1997
• Practical Rheumatology 
  Chapter: Clinical features of systemic sclerosis. 
  Page 329 - 342Seibold JREditors: Klippel JH, Dieppe PA.Mosby, LondonEdition 1st,1995
• Systemic Sclerosis 
  Chapter: Treatment of Systemic Sclerosis by Disease Modifying Agents. 
  Page 535 - 548Seibold JR, Clements PJ, Furst DEEditors: Furst DE, Clements PJ.Williams & Wilkins, PhiladelphiaEdition 1st,1995
• Systemic Sclerosis 
  Chapter: Controlled Trials: Trial Design Issues. 
  Page 515 - 533Clements PJ, Furst DE, Seibold JR, Lachenbruch PAEditors: Furst DE, Clements PJ.Williams & Wilkins, PhiladelphiaEdition 1st,1995
• Essentials of Internal Medicine 
  Chapter: Raynaud's Phenomenon and Scleroderma. 
  Page 291 - 294Seibold JREditors: Kelley WN.J.B. Lippincott, PhiladelphiaEdition 1st,1994
• Rheumatology 
  Chapter: Clinical Features of Systemic Sclerosis. 
  Seibold JREditors: Klippel JH, Dieppe P.LondonEdition 1st,1994
• Textbook of Internal Medicine 
  Chapter: Scleroderma. 
  Page 939 - 942Seibold JREditors: Kelley WN.J.B. Lippincott, PhiladelphiaEdition 2nd,1992
• Textbook of Rheumatology 
  Chapter: Scleroderma. 
  Page 1215 - 1244Seibold JREditors: Kelley WN, Harris ED, Ruddy S., Sledge CB.W. B. Saunders, PhiladelphiaEdition 3rd,1989
• Textbook of Internal Medicine 
  Chapter: The care of patients with Raynaud's phenomenon and scleroderma. 
  Page 1103 - 1106Seibold JREditors: Kelley WN.J.B. Lippincott, Philadelphia1989
• Textbook of InternalMedicine 
  Chapter: Scleroderma. 
  Page 1003 - 1007Seibold JREditors: Kelley WN.J.B. Lippincott, Philadelphia1989
• Join now to see all

Abstracts/Posters

• Safety and tolerability of pirfenidone in patients with systemic sclerosis-associated interstitial lung disease-the LOTUSS Study.
  Khanna D, Albera C, Fischer A, Khalidi N, Raghu G, Chung L, Schiopu E, Chen D, Gorina E, Tagliaferri M, Seibold JR, Arthritis Rheum, ATS, EULAR, ERS and ACR, 1/1/2015
• Development of a combined response index for clinical trials in early diffuse systemic sclerosis-the CRISS index.
  Khanna D, Berrocal V, Giannini E, Mayes M. Merkel P, Seibold J, Baron M, Clements P, Steen V, Lovell D, Siegel J, Distler O, Allanore Y, Czirjak L, Denton CP, Johnson ..., Arthritis Rheum, 1/1/2014
• Developing a disease activity and therapeutic response index in connective tissue disease related interstitial lung disease: initial results of a Delphi exercise.
  Saketkoo L, Huscher D, Khanna D, Dellaripa P, Flaherty K, Matteson EL, Oddis CV, Phillips K, Wells A, Denton CP, Distler O, Kowal-Bielecka O, Pittrow D, Strand V, Brow..., Ann Rheum Dis, 1/1/2013
• An evidence-based tool for detection of pulmonary arterial hypertension in systemic sclerosis: The DETECT study.
  Denton CP, Coghlan JG, Gruenig E, Bonderman D, Distler O, Khanna D, Mueller-Ladner U, Pope J, Vonk M, Doelberg M, Chadha-Boreham H, Heinzl H, Rosenberg D, McLaughlin V..., Ann Rheum Dis, 1/1/2013
• Baseline characteristics of systemic sclerosis patients with borderline mean pulmonary artery pressure: post hoc analysis from the DETECT study.
  Khanna D, Distler O, Coghlan JG, Denton CP, Gruenig E, Bonderman D, Mueller-Ladner U, Pope J,Vonk M, Torres-Martin J-V, Doelberg M, Chadha-Boreham H, Heinzl H, Rosenbe..., Ann Rheum Dis, 1/1/2013
• Pulmonary arterial hypertension in the connective tissue diseases-the new era of evidence.
  Seibold JR, Ann Rheum Dis, 1/1/2013
• Developing a disease activity and therapeutic response index in connective tissue disease related interstitial lung disease: initial results of a Delphi exercise.
  Saketkoo L, Huscher D, Khanna D, Dellaripa P, Flaherty K, Matteson EL, Oddis CV, Phillips K, Wells A, Denton CP, Distler O, Kowal-Bielecka O, Pittrow D, Strand V, Brow..., Arthritis Rheum, 1/1/2012
• An evidence-based screening algorithm for pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
  McLaughlin VV, Coghlan JG, Denton CP, Gruenig E, Bonderman D, Distler O, Khanna D, Mueller-Ladner U, Pope J, Vonk M, Doelberg M, Chadha-Boreham H, Heinzl H, Rosenberg ..., Chest, 1/1/2012
• An evidence-based screening algorithm for pulmonary arterial hypertension in systemic sclerosis.
  Seibold JR, Denton CP, Gruenig E, Bonderman D, Distler O, Khanna D, Mueller-Ladner U, Pope J, Vonk M, Doelberg M, Chadha-Boreham H, Heinzl H, Rosenberg D, McLaughlin V..., Arthritis Rheum, 1/1/2012
• Developing an index for disease activity and therapeutic response in connective tissue disease related interstitial lung disease: results from a Delphi consensus: deli...
  Saketkoo LA, Huscher D, Khanna D, Dellaripa PF, Flaherty K, Oddis CV, Philips K, Wells A, Denton CP, Distler O, Kowal-Bielecka OM, Sandorfi N, Souza R, Pittrow D, Stra..., Arthritis Rheum, 1/1/2012
• Combined response index in diffuse systemic sclerosis (CRISS)-which external anchors to use when developing the index? Baseline analysis.
  Khanna D, Berrocal V, Seibold JR, Merkel PA, Mayes MD, Phillips K, Simms R, Assassi S, Clements PJ, Wong WK, Furst DE, Arthritis Rheum, 1/1/2012
• Comparison of baseline characteristics of the CRISS cohort to patients enrolled in clinical trials of diffuse systemic sclerosis.
  Gladue H, Furst DE, Berrocal VJ, Seibold JR, Merkel PA, Mayes MD, Phillips K, Simms R, Assassi S, Clements PJ, Maranian P, Khanna D, Arthritis Rheum, 1/1/2012
• EULAR Points to Consider for clinical trials in systemic sclerosis.
  Khanna D, Walker U, Mueller-Ladner U, Singh M, Bodukam V, Bae S, Allanore Y, Clements P, Cutolo M, Czirjak L, Denton CP, Distler O, Matucci M, Seibold J, Tyndall A, Fu..., Proc EULAR, 1/1/2011
• Oxidation of protein tyrosine phosphatase-1B leads to pronounced PDGFR activation in scleroderma fibroblasts.
  Tsou P-S, Pinney AJ, Talia NN, Piera S, Jimenez S, Seibold JR, Phillips K, Koch AE, Arthritis Rheum, 1/1/2011
• Construct validity of the Saint George's Respiratory Questionnaire in an observational cohort of patients with early diffuse systemic sclerosis.
  Khanna D, Seibold JR, Merkel PA, Mayes MD, Phillips K, Simms R, Assassi S, Clements P, Furst DE, Arthritis Rheum, 1/1/2011
• Digital ischemic ulcers in scleroderma treated with oral treprostinil diethanolamine: a randomized, double-blind, placebo-controlled, multicenter study.
  Seibold JR, Wigley FM, Schiopu E, Denton CP, Silver RM, Steen VD, Medsger TA, Mayes MD, Chatterjee S, Chung L, Csuka ME, Khanna D, Collier D, Frech TM, Molitor J, Roth..., Arthritis Rheum, 1/1/2011
• Patients with systemic sclerosis (SSc) enrolled in the Scleroderma Lung Study (SLS) have a high mortality within 5 Years of Stopping cyclophosphamide (CYC).
  Furst DE, Khanna D, Tseng CH, Mayes M, Roth M, Seibold J, Simms RW, Elashoff R, Hsu VM, Sullivan KM, Tashkin D, Clin Exp Rheumatol, 1/1/2010
• Denials of treatment coverage by health insurance carriers restrict patient recruitment on a randomized clinical trial: experience of 95 patients with systemic scleros...
  Sullivan KM, Seibold JR, Mineishi S et al, Proc 2010 Bone Marrow Transplant Tandem Meeting, 1/1/2010
• Pulmonary artery diameter is associated with pulmonary hypertension in patients with systemic sclerosis (SSc).
  Schiopu E, Impens AJ, Gross BH, Phillips K, Seibold JR, Clin Exp Rheumatol, 1/1/2010
• Management of systemic sclerosis according to stage and subset of disease.
  Seibold JR, Clin Exp Rheumatol, 1/1/2010
• Clinical and histopathological comparison of generalized subcutaneous morphea (GSM) with eosinophilic fasciitis.
  Mahmood F, Impens A, Schiopu E, Phillip K, Lowe L, Olsen S, Seibold JR, Clin Exp Rheumatol, 1/1/2010
• The DETECT Study: a two-stage, prospective, observational, cohort study in scleroderma patients to evaluate screening tests and the incidence of pulmonary hypertension.
  Vonk M, Coghlan G, Bonderman D, Denton C, Distler O, Gruenig E, Khanna D, McLaughlin V, Mueller-Ladner U, Pope J, Seibold J, Clin Exp Rheumatol, 1/1/2010
• Prognostic role of ECG in puilmonary hypertension associated with systemic sclerosis (SSc).
  Phillips K, Byrne-Dugan C, Schiopu E, Impens A, Mahmood F, Seibold J, Clin Exp Rheumatol, 1/1/2010
• Phosphorylation of PDGFR in skin biopsies of patients with scleroderma.
  Phillips K, Schiopu E, Maher R, Mathews R, McDonald S, Stewart Z, Gerber M, Impens A, Seibold JR, Clin Exp Rheumatol, 1/1/2010
• Denials of treatment coverage by health insurance carriers restrict patient recruitment on a randiomized clinical trial: experience of 95 U.S. patients with systemic s...
  Sullivan K, Seibold J, Mayes M, Csuka ME, Nash R, Simms R, Furst D, Clin Exp Rheumatol, 1/1/2010
• Join now to see all

Lectures

• "Emerging Therapies" 
  Lisbon, Portugal - 1/1/2016
• "Keynote Lecture: Early stage scleroderma trial design in the 21st century" 
  Cambridge, UK - 1/1/2015
• "The challenge of clinical trials in scleroderma" 
  Cambridge, UK - 1/1/2015
• "Advancing Potential Drugs to Patient Care"-Trial Design and Outcome measures 
  1/1/2015
• "Registries and their Uses in Scleroderma Research" 
  Boston, MA - 1/1/2014
• "The role of corticosteroids in systemic sclerosis" 
  Rome, Italy - 1/1/2014
• "Targeting vascular remodeling and PAH in systemic sclerosis" 
  Madrid, Spain - 1/1/2013
• "Pulmonary Hypertension in Scleroderma" 
  Rochester Medical School - 1/1/2013
• "Successes and Failures of our Community in Randomized Controlled Trials" 
  Monteriggioni, Italy - 1/1/2013
• "Assessment and management of ILD" 
  Mannheim, Germany - 1/1/2013
• "Meet the Professor-PAH in the Connective Tissue Diseases" 
  San Diego, CA - 1/1/2013
• "Future Directions in Research" 
  Washington, DC - 1/1/2012
• "Rheumatologist's Perspective on Pulmonary Hypertension" 
  Altoona, PA - 1/1/2012
• "Lung Involvement in Systemic Sclerosis" 
  Istituto Gaetano Pini & Ospedale Maggiore del Policlinico, Milan, Italy; Universita degli Studi Fede - 1/1/2011
• "Pulmonary Arterial Hypertension in SSc: Challenges in Recognition and Management" 
  Istituto Gaetano Pini & Ospedale Maggiore del Policlinico, Milan, Italy; Universita degli Studi Fede - 1/1/2011
• "Disease Severity" 
  Belgrade, Serbia - 1/1/2011
• "Update on Lung Involvement in Systemic Sclerosis" 
  New York University Medical School, New York, NY - 1/1/2011
• "Webinar-Clinical Research in Scleroderma" 
  San Francisco, CA - 1/1/2011
• "The multicolour world of cold hands and feet" 
  London, United Kingdom - 1/1/2011
• "Clinical Trial Strategies in Systemic Sclerosis" 
  Boston University School of Medicine, Boston, MA - 1/1/2011
• "Scleroderma: A Treatable Multisystem Disease" 
  Chicago, IL - 1/1/2011
• "Cardiac Complications and Connective Tissue Disease and the Future Therapy of Pulmonary Arterial Hypertension" 
  University of Toledo - 1/1/2010
• "Management of systemic sclerosis according to stage and subset of disease" 
  Florence, Italy - 1/1/2010
• "SSc-PAH: The Current Outlook and Future Paradigms" 
  Florence, Italy - 1/1/2010
• "Trial Design and Feasibility in Scleroderma Associated PAH" 
  Florence, Italy - 1/1/2010
• Join now to see all

Other

• Raynaud Phenomenon-A Guide to Pathogenesis and Treatment 
  Khanna D, Gladue H, Seibold JR
  1/1/2014
• Module 1-Pathogenesis-An Overview. 
  Distler O, Denton CP, Seibold JR, EUSTAR Online Course in Systemic Sclerosis
  http://www.eular-ssc-onlinecourse.org/
  1/1/2012
• Module 9 Management-Vasodilators. 
  Riemekasten G, Seibold JR, EUSTAR Online Course in Systemic Sclerosis
  http://www.eular-ssc-onlinecourse.org/
  1/1/2012
• Expert Analysis from the 2011 MidWest Rheumatology Summit. 
  Seibold JR, Rheumatology News
  1/1/2011
• Progress continues in systemic sclerosis: Advances in genetics and potential therapies shed new light on the disease. 
  Furst DE, Myes MD, Khanna D, Seibold JR, Saggar R, Sullivan KM, The Rheumatologist
  1/1/2010
• Are serum biomarkers better for PAH screening in scleroderma? 
  Seibold JR, Opinion Update
  http://www.mdprimer.com/opinionupodate
  1/1/2010
• Systemic sclerosis: progress continues. 
  Furst DE, Mayes MD, Khanna D, Seibold JR, Saggar R, Sullivan K, The Rheumatologist
  1/1/2010
• Progress through collaboration in scleroderma. 
  Seibold JR, ISN Newsletter
  1/1/2009
• PH and Scleroderma. 
  Seibold JR, Pulmonary Hypertension Association Pamphlets for Physicians and Patients
  1/1/2009
• Progressi scientifici nell'ipertensione arteriosa polmonare. 
  Seibold JR, Matucci-Cerinic M, Denton CP, Elsevier
  1/1/2009
• Progress in Clinical Research-How to Measure Success. 
  Seibold JR, ISN Newsletter
  1/1/2009
• A rheumatologist's perspective on pulmonary arterial hypertension in patients with connective tissue disease. 
  Seibold JR, Steen VD, Rush University Medical Center
  www.cmetests.com
  1/1/2008
• Scleroderma QuERI, Introduction. 
  Seibold JR
  http://www.mdprimer.com
  1/1/2008
• Detection and management of pulmonary hypertension in scleroderma. 
  Seibold JR, Opinion Update
  http://www.mdprimer.com/opinionupdate
  1/1/2008
• Progress in Scleroderma. 
  Seibold JR, Scleroderma Society (UK) Newsletter
  1/1/2008
• The Scleroderma QuERI-Challenges and Progress. 
  Seibold JR, Opinion Update
  http://www.mdprimer.com/opinionupdate
  1/1/2008
• Raynaud's Phenomenon 
  Seibold JR, Patient Brochure, Arthritis Foundation
  1/1/2008
• Terapia delle ulcere digitiali: e possible un approccio preventivo? Trattamento della sclerodermia. 
  Seibold JR, Congresso Nazionale Societa di Rheumatologia Programma
  1/1/2007
• I have scleroderma. Is exercise good for me? 
  Seibold JR, ISN Newsletter
  1/1/2007
• What is pulmonary hypertension? 
  Seibold JR, ISN Newsletter
  1/1/2007
• Advances in treatment of pulmonary hypertension. 
  Seibold JR, Denton CD, PeerViewPress
  http://www.peerviewpress.com/284
  1/1/2007
• Bridging the care gap in scleroderma lung-The web cast. 
  Seibold JR, Furst DE, Mayes MD, Steen VD
  http://www.mdprimer.com/ScleroIntro.aspx
  1/1/2007
• Is there a test to accurately assess skin involvement in scleroderma? 
  Seibold JR, ISN Insider Newsletter
  1/1/2005
• "Pulmonary Hypertension in the Connective Tissue Diseases" 
  Seibold Jr, Widlitz A, McGoon M, Shedding Light on Pulmonary Arterial Hypertension (CD-ROM CME), Pulmonary Hypertension Association
  Silver Spring, MD - 1/1/2005
• What in the world is scleroderma. 
  Seibold JR, Ensz S, Patient Education Pamplet
  International Scleroderma Network, Endina, MN - 1/1/2004
• Join now to see all